45 research outputs found
Acute Non Lymphoid Leukemia following CMF Treatment as Adjuvant Therapy in Positive Node Breast Cancer
No full text
Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Letrozole or Anastrozole. A Phase II Trial Conducted by the Hellenic Group of Oncology (HELGO)
No full textErratum: Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: Results of a survival update based on a combined analysis of data from two mature phase III trials (Cancer (1998) 83 (1142-1152))
No full text104. Randomized phase III study of the new selective aromatase inhibitor arimidex (A) (ZD1033) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer
No full textInteraction between Doxorubicin and Mitomycin C on Mortality and Myocardial Contractility in Guinea PIG
No full text
Congresso AIOM 2004 Endocrinoterapia e Gestione di Pazienti con Metastasi Ossee da Carcinoma Mammario
No full textCorrelation between response to neoadjuvant chemotherapy (NACT) with single agent taxanes and HER-2 gene amplification in patients with breast carcinoma
No full textHormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
No full textBackground: The aim of this study was to compare the extent of pathologic response in patients with HER2-positive (HER2+) breast cancer treated with standard neoadjuvant chemotherapy, with or without trastuzumab (H), according to hormone receptor (HR) status
